{"transactions":[{"id":905449,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66529,"kind":"person","name":"McKean-Dieser Avril Suzette","position":1,"cik":"0002042392","reported_name":"McKean-Dieser Avril Suzette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-02-13T16:43:41.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 22, 2026, the reporting person was granted options to purchase 50,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as a director of the issuer on such date."}],"balance_after":50000,"derivative":{"exercise_price":1.34,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-26-016508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042392/000121390026016508/ownership.xml","form_type":"4"}},{"id":962251,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66529,"kind":"person","name":"McKean-Dieser Avril Suzette","position":1,"cik":"0002042392","reported_name":"McKean-Dieser Avril Suzette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-12-19T18:30:04.000Z","date":"2025-10-21","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 21, 2025, the reporting person was granted options to purchase 140,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as a director of the issuer on such date."}],"balance_after":140000,"derivative":{"exercise_price":1.8,"expiration_date":"2035-10-21","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001213900-25-123992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042392/000121390025123992/ownership.xml","form_type":"4"}},{"id":1267770,"issuer":{"id":6950,"kind":"organization","name":"OS Therapies Inc","symbol":"OSTX"},"owners":[{"id":66529,"kind":"person","name":"McKean-Dieser Avril Suzette","position":1,"cik":"0002042392","reported_name":"McKean-Dieser Avril Suzette","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock options (right to buy)","published_at":"2025-02-14T16:24:49.000Z","date":"2024-12-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 40,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 5, 2024, the reporting person was granted non-qualified stock options to purchase 40,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and subject to certain vesting conditions."}],"balance_after":40000,"derivative":{"exercise_price":1.86,"underlying":"Common stock, par value $0.001 per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000921895-25-000496","document":"form513679001mck_02142025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042392/000092189525000496/form513679001mck_02142025.xml","form_type":"5"}}]}